Treasury to propose rule restricting U.S. investment in Chinese biotech

Unconfirmed reports indicate the U.S. Treasury will this week propose a rule limiting American investment in China's biotech sector, likely under the outbound investment screening program. The scope and specific subsectors remain unclear, and the rule's impact on cross-border capital flows and U.S.-China tech decoupling is significant.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works